MyLeukemiaTeam

What treatment regimens do most people with AML follow?

Your current regimen of venetoclax combined with azacitidine is actually one of the standard treatment approaches for AML. This combination is commonly used and recognized as an effective option.

Most people with AML follow a treatment plan that typically includes Show Full Answer

What treatment regimens do most people with AML follow?

Your current regimen of venetoclax combined with azacitidine is actually one of the standard treatment approaches for AML. This combination is commonly used and recognized as an effective option.

Most people with AML follow a treatment plan that typically includes two main phases:

- Remission induction therapy: The first phase aims to kill as many leukemia cells as possible to achieve remission
- Consolidation therapy: The second phase destroys any remaining cancer cells to prevent relapse

Some treatment plans also include a maintenance phase using lower doses of medication over one to two years.

Common chemotherapy drugs used for AML include cytarabine, daunorubicin, idarubicin, fludarabine, and cladribine. Many people receive combinations of these medications.

In recent years, targeted therapies have become more common. The FDA has approved seven to eight oral targeted therapy drugs in just the past two years. These can often be taken at home rather than requiring clinic visits.

Your specific treatment plan depends on factors like your AML subtype, age, genetic mutations, and overall health. The regimen you're on with venetoclax and azacitidine is designed to effectively target your leukemia while allowing recovery time between cycles.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Acute Myeloid Leukemia: Your Guide

Acute Myeloid Leukemia Treatment Options